Press Release | Wed Feb 5, 2014 6:40am EST

Merck Enters Strategic Collaborations with Amgen, Incyte and Pfizer to Evaluate Novel Combination Anti-cancer Regimens with MK-3475

* Reuters is not responsible for the content in this press release.